Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response.

Pantaleo MA, Tarantino G, Agostinelli C, Urbini M, Nannini M, Saponara M, Castelli C, Stacchiotti S, Fumagalli E, Gatto L, Santini D, De Leo A, Marafioti T, Akarca A, Sabattini E, Pession A, Ardizzoni A, Indio V, Astolfi A.

Oncoimmunology. 2019 Jun 4;8(9):e1617588. doi: 10.1080/2162402X.2019.1617588. eCollection 2019.

2.

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.

Stacchiotti S, Ferrari S, Redondo A, Hindi N, Palmerini E, Vaz Salgado MA, Frezza AM, Casali PG, Gutierrez A, Lopez-Pousa A, Grignani G, Italiano A, LeCesne A, Dumont S, Blay JY, Penel N, Bernabeu D, de Alava E, Karanian M, Morosi C, Brich S, Dagrada GP, Vallacchi V, Castelli C, Brenca M, Racanelli D, Maestro R, Collini P, Cruz J, Martin-Broto J.

Lancet Oncol. 2019 Sep;20(9):1252-1262. doi: 10.1016/S1470-2045(19)30319-5. Epub 2019 Jul 19. Erratum in: Lancet Oncol. 2019 Oct;20(10):e559.

PMID:
31331701
3.

Automated measurement of tracheal and main bronchial diameters: a feasibility study.

Ma S, Adjavon S, Bouchiha N, Castelli C, Fischler M, Mellot F, Le Guen M.

Minerva Anestesiol. 2019 May 14. doi: 10.23736/S0375-9393.19.13458-X. [Epub ahead of print]

PMID:
31106553
4.

Metal ion trend in patients with metal-on-metal total hip arthroplasty: a 10-year prospective study.

Sangaletti R, Spreafico A, Barbieri F, Ferrari R, Castelli CC.

Hip Int. 2018 Nov;28(2_suppl):43-47. doi: 10.1177/1120700018812991.

PMID:
30755113
5.

A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia.

Dauriz M, Maneschi C, Castelli C, Tomezzoli A, Fuini A, Landoni L, Malleo G, Ferdeghini M, Bonora E, Moghetti P.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):773-778. doi: 10.1210/jc.2018-02007.

PMID:
30597028
6.

Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types.

Tazzari M, Brich S, Tuccitto A, Bozzi F, Beretta V, Spagnuolo RD, Negri T, Stacchiotti S, Deraco M, Baratti D, Camisaschi C, Villa A, Vergani B, Rivoltini L, Pilotti S, Castelli C.

J Immunol Res. 2018 Oct 29;2018:5804230. doi: 10.1155/2018/5804230. eCollection 2018.

7.

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk.

Fortunato O, Borzi C, Milione M, Centonze G, Conte D, Boeri M, Verri C, Moro M, Facchinetti F, Andriani F, Roz L, Caleca L, Huber V, Cova A, Camisaschi C, Castelli C, Cancila V, Tripodo C, Pastorino U, Sozzi G.

Int J Cancer. 2019 Jun 1;144(11):2746-2761. doi: 10.1002/ijc.31988. Epub 2019 Jan 6.

8.

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Tuccitto A, Shahaj E, Vergani E, Ferro S, Huber V, Rodolfo M, Castelli C, Rivoltini L, Vallacchi V.

Virchows Arch. 2019 Apr;474(4):407-420. doi: 10.1007/s00428-018-2477-z. Epub 2018 Oct 29. Review.

PMID:
30374798
9.

The diagnostic use of ADVIA 2120i Siemens and an "APL criteria" can help to reduce the rate of early death in the APL.

Rocco V, Castelli C, Fumi M, Mancini F, Pancione Y, Prisciandaro M, Sale S, Tanca D, Vagnoni D.

Int J Lab Hematol. 2019 Feb;41(1):124-132. doi: 10.1111/ijlh.12935. Epub 2018 Oct 24.

PMID:
30358123
10.

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients.

Camisaschi C, Renne SL, Beretta V, Rini F, Spagnuolo RD, Tuccitto A, Podda MG, Parmiani G, Rivoltini L, Collini P, Castelli C, Luksch R.

BMC Cancer. 2018 Oct 16;18(1):983. doi: 10.1186/s12885-018-4910-8.

11.

Risk of new-onset urinary incontinence 3 and 12 months after vaginal or cesarean delivery of twins: Part I.

de Tayrac R, Béchard F, Castelli C, Alonso S, Vintejoux E, Goffinet F, Letouzey V, Schmitz T.

Int Urogynecol J. 2019 Jun;30(6):881-891. doi: 10.1007/s00192-018-3774-4. Epub 2018 Oct 6.

PMID:
30293167
12.

Impact of mode of delivery of twins on the pelvic floor 3 and 12 months post-partum-part II.

Béchard F, Castelli C, Alonso S, Vintejoux E, Goffinet F, Letouzey V, Schmitz T, de Tayrac R.

Int Urogynecol J. 2019 Jun;30(6):893-899. doi: 10.1007/s00192-018-3785-1. Epub 2018 Oct 5.

PMID:
30291380
13.

Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases.

Le Noci V, Guglielmetti S, Arioli S, Camisaschi C, Bianchi F, Sommariva M, Storti C, Triulzi T, Castelli C, Balsari A, Tagliabue E, Sfondrini L.

Cell Rep. 2018 Sep 25;24(13):3528-3538. doi: 10.1016/j.celrep.2018.08.090.

14.

Analgesic gas for rehabilitation of frozen shoulder: Protocol for a randomized controlled trial.

Dupeyron A, Dénarié M, Richard D, Dobija L, Castelli C, Petiot S, Tavares I, Gelis A, Coudeyre E.

Ann Phys Rehabil Med. 2019 Jan;62(1):43-48. doi: 10.1016/j.rehab.2018.07.007. Epub 2018 Aug 9.

PMID:
30099150
15.

Cost analysis of prostate cancer detection including the prostate health index (phi).

Mathieu R, Castelli C, Fardoun T, Peyronnet B, Shariat SF, Bensalah K, Vincendeau S.

World J Urol. 2019 Mar;37(3):481-487. doi: 10.1007/s00345-018-2362-z. Epub 2018 Jul 6.

PMID:
29980838
16.

pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma.

Kuchuk O, Tuccitto A, Citterio D, Huber V, Camisaschi C, Milione M, Vergani B, Villa A, Alison MR, Carradori S, Supuran CT, Rivoltini L, Castelli C, Mazzaferro V.

Oncoimmunology. 2018 Mar 26;7(7):e1445452. doi: 10.1080/2162402X.2018.1445452. eCollection 2018.

17.

Can Clinical and Surgical Parameters Be Combined to Predict How Long It Will Take a Tibia Fracture to Heal? A Prospective Multicentre Observational Study: The FRACTING Study.

Massari L, Benazzo F, Falez F, Cadossi R, Perugia D, Pietrogrande L, Aloj DC, Capone A, D'Arienzo M, Cadossi M, Lorusso V, Caruso G, Ghiara M, Ciolli L, La Cava F, Guidi M, Castoldi F, Marongiu G, La Gattuta A, Dell'Omo D, Scaglione M, Giannini S, Fortina M, Riva A, De Palma PL, Gigante AP, Moretti B, Solarino G, Lijoi F, Giordano G, Londini PG, Castellano D, Sessa G, Costarella L, Barile A, Borrelli M, Rota A, Fontana R, Momoli A, Micaglio A, Bassi G, Cornacchia RS, Castelli C, Giudici M, Monesi M, Branca Vergano L, Maniscalco P, Bulabula M, Zottola V, Caraffa A, Antinolfi P, Catani F, Severino C, Castaman E, Scialabba C, Tovaglia V, Corsi P, Friemel P, Ranellucci M, Caiaffa V, Maraglino G, Rossi R, Pastrone A, Caldora P, Cusumano C, Squarzina PB, Baschieri U, Demattè E, Gherardi S, De Roberto C, Belluati A, Giannini A, Villani C, Persiani P, Demitri S, Di Maggio B, Abate G, De Terlizzi F, Setti S.

Biomed Res Int. 2018 Apr 30;2018:1809091. doi: 10.1155/2018/1809091. eCollection 2018.

18.

Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.

Ponziani FR, Bhoori S, Castelli C, Putignani L, Rivoltini L, Del Chierico F, Sanguinetti M, Morelli D, Paroni Sterbini F, Petito V, Reddel S, Calvani R, Camisaschi C, Picca A, Tuccitto A, Gasbarrini A, Pompili M, Mazzaferro V.

Hepatology. 2019 Jan;69(1):107-120. doi: 10.1002/hep.30036. Epub 2018 Jul 10.

PMID:
29665135
19.

[Nutritional status of residents of a nursing home and optimisation of the working time of caregivers].

Falesse S, Barat P, Castelli C, Antoine V, Chkair S, Bouvet S, Pouysségur V.

Soins Gerontol. 2018 Jan - Feb;23(129):23-28. doi: 10.1016/j.sger.2017.11.005. French.

PMID:
29335137
20.

Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study).

Leguelinel-Blache G, Castelli C, Roux-Marson C, Bouvet S, Andrieu S, Cestac P, Collomp R, Landais P, Loulière B, Mouchoux C, Varin R, Allenet B; MEDREV Working Group, Bedouch P, Kinowski JM.

Trials. 2018 Jan 8;19(1):19. doi: 10.1186/s13063-017-2412-7.

21.

Tracheal extubation with suction vs. positive pressure during emergence from general anaesthesia in adults: A randomised controlled trial.

L'Hermite J, Wira O, Castelli C, de La Coussaye JE, Ripart J, Cuvillon P.

Anaesth Crit Care Pain Med. 2018 Apr;37(2):147-153. doi: 10.1016/j.accpm.2017.07.005. Epub 2017 Sep 4.

PMID:
28882741
22.

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, Tuccitto A, Tagliabue E, Castelli C, Rivoltini L.

Semin Cancer Biol. 2017 Apr;43:74-89. doi: 10.1016/j.semcancer.2017.03.001. Epub 2017 Mar 6. Review.

23.

Reliability of automated synovial fluid cell counting with Mindray BC-6800 body fluid mode.

Buoro S, Seghezzi M, Manenti B, Mecca T, Candiago E, Vidali M, Ottomano C, Castelli CC, Ferrari R, Zappalà G, Lippi G.

Int J Lab Hematol. 2017 Jun;39(3):337-346. doi: 10.1111/ijlh.12632. Epub 2017 Mar 6.

PMID:
28263031
24.

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.

Vallacchi V, Camisaschi C, Dugo M, Vergani E, Deho P, Gualeni A, Huber V, Gloghini A, Maurichi A, Santinami M, Sensi M, Castelli C, Rivoltini L, Rodolfo M.

Genes (Basel). 2016 Dec 14;7(12). pii: E124.

25.

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer.

Camisaschi C, Vallacchi V, Vergani E, Tazzari M, Ferro S, Tuccitto A, Kuchuk O, Shahaj E, Sulsenti R, Castelli C, Rodolfo M, Rivoltini L, Huber V.

Vaccines (Basel). 2016 Nov 4;4(4). pii: E38. Review.

26.

Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.

Tazzari M, Indio V, Vergani B, De Cecco L, Rini F, Negri T, Camisaschi C, Fiore M, Stacchiotti S, Dagrada GP, Casali PG, Gronchi A, Astolfi A, Pantaleo MA, Villa A, Lombardo C, Arienti F, Pilotti S, Rivoltini L, Castelli C.

J Invest Dermatol. 2017 Feb;137(2):484-493. doi: 10.1016/j.jid.2016.06.634. Epub 2016 Sep 5.

27.

Optimization of Cellular analysis of Synovial Fluids by optical microscopy and automated count using the Sysmex XN Body Fluid Mode.

Seghezzi M, Buoro S, Manenti B, Mecca T, Ferrari R, Zappalà G, Castelli CC, Balboni F, Pezzati P, Ottomano C, Lippi G.

Clin Chim Acta. 2016 Nov 1;462:41-48. doi: 10.1016/j.cca.2016.08.018. Epub 2016 Aug 28.

PMID:
27581597
28.

Impact of ATLS guidelines, trauma team introduction, and 24-hour mortality due to severe trauma in a busy, metropolitan Italian hospital: A case control study.

Magnone S, Allegri A, Belotti E, Castelli CC, Ceresoli M, Coccolini F, Manfredi R, Merli C, Palamara F, Piazzalunga D, Valetti TM, Ansaloni L.

Ulus Travma Acil Cerrahi Derg. 2016 May;22(3):242-6. doi: 10.5505/tjtes.2015.19540.

29.

In myotonic dystrophy type 1 reduced FDG-uptake on FDG-PET is most severe in Brodmann area 8.

Renard D, Collombier L, Castelli C, Pouget JP, Kotzki PO, Boudousq V.

BMC Neurol. 2016 Jul 13;16:100. doi: 10.1186/s12883-016-0630-3.

30.

Density heterogeneity and fluid-blood levels in patients aged over 55 with lobar hematoma.

Renard D, Waconge A, Bouly S, Castelli C, Thouvenot E.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):379-83. doi: 10.1016/j.neurol.2016.05.003. Epub 2016 Jun 20.

PMID:
27338204
31.

Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours.

Spagnuolo RD, Brich S, Bozzi F, Conca E, Castelli C, Tazzari M, Maestro R, Brenca M, Gualeni AV, Gloghini A, Stacchiotti S, Pierotti MA, Pilotti S, Negri T.

Oncotarget. 2016 Jul 19;7(29):45015-45026. doi: 10.18632/oncotarget.7523.

32.

Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells.

Tuccitto A, Tazzari M, Beretta V, Rini F, Miranda C, Greco A, Santinami M, Patuzzo R, Vergani B, Villa A, Manenti G, Cleris L, Giardiello D, Alison M, Rivoltini L, Castelli C, Perego M.

Stem Cells. 2016 Oct;34(10):2449-2460. doi: 10.1002/stem.2413. Epub 2016 Jun 28.

33.

Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.

Stacchiotti S, Astolfi A, Gronchi A, Fontana A, Pantaleo MA, Negri T, Brenca M, Tazzari M, Urbini M, Indio V, Colombo C, Radaelli S, Brich S, Dei Tos AP, Casali PG, Castelli C, Dagrada GP, Pilotti S, Maestro R.

Mol Cancer Res. 2016 Sep;14(9):820-9. doi: 10.1158/1541-7786.MCR-16-0068. Epub 2016 Jun 2.

34.

Rotational alignment of the femoral component in total knee arthroplasty.

Castelli CC, Falvo DA, Iapicca ML, Gotti V.

Ann Transl Med. 2016 Jan;4(1):4. doi: 10.3978/j.issn.2305-5839.2015.12.66. Review.

35.

Open pelvic fracture associated with lumbosacral dislocation and extensive perineal injury.

Rizzi L, Castelli C.

Injury. 2015 Dec;46 Suppl 7:S44-7. doi: 10.1016/S0020-1383(15)30045-0.

PMID:
26738461
36.

Improving Patient's Primary Medication Adherence: The Value of Pharmaceutical Counseling.

Leguelinel-Blache G, Dubois F, Bouvet S, Roux-Marson C, Arnaud F, Castelli C, Ray V, Kinowski JM, Sotto A.

Medicine (Baltimore). 2015 Oct;94(41):e1805. doi: 10.1097/MD.0000000000001805.

37.

Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).

Stacchiotti S, Pantaleo MA, Negri T, Astolfi A, Tazzari M, Dagrada GP, Urbini M, Indio V, Maestro R, Gronchi A, Fiore M, Dei Tos AP, Conca E, Palassini E, Vincenzi B, Grosso F, Pilotti S, Castelli C, Casali PG.

Clin Cancer Res. 2016 Feb 15;22(4):837-46. doi: 10.1158/1078-0432.CCR-15-1243. Epub 2015 Aug 10.

38.

Consensus nomenclature for CD8+ T cell phenotypes in cancer.

Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, Comin-Anduix B, Coukos G, Dhodapkar MV, Dranoff G, Frazer IH, Fridman WH, Gabrilovich DI, Gilboa E, Gnjatic S, Jäger D, Kalinski P, Kaufman HL, Kiessling R, Kirkwood J, Knuth A, Liblau R, Lotze MT, Lugli E, Marincola F, Melero I, Melief CJ, Mempel TR, Mittendorf EA, Odun K, Overwijk WW, Palucka AK, Parmiani G, Ribas A, Romero P, Schreiber RD, Schuler G, Srivastava PK, Tartour E, Valmori D, van der Burg SH, van der Bruggen P, van den Eynde BJ, Wang E, Zou W, Whiteside TL, Speiser DE, Pardoll DM, Restifo NP, Anderson AC.

Oncoimmunology. 2015 Feb 25;4(4):e998538. eCollection 2015 Apr.

39.

A multicenter, randomized, controlled trial of osteopathic manipulative treatment on preterms.

Cerritelli F, Pizzolorusso G, Renzetti C, Cozzolino V, D'Orazio M, Lupacchini M, Marinelli B, Accorsi A, Lucci C, Lancellotti J, Ballabio S, Castelli C, Molteni D, Besana R, Tubaldi L, Perri FP, Fusilli P, D'Incecco C, Barlafante G.

PLoS One. 2015 May 14;10(5):e0127370. doi: 10.1371/journal.pone.0127370. eCollection 2015.

40.

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity.

Castelli C, Triebel F, Rivoltini L, Camisaschi C.

Oncoimmunology. 2014 Dec 21;3(11):e967146. eCollection 2014 Nov.

41.

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report.

Tazzari M, Palassini E, Vergani B, Villa A, Rini F, Negri T, Colombo C, Crippa F, Morosi C, Casali PG, Pilotti S, Stacchiotti S, Rivoltini L, Castelli C.

BMC Cancer. 2015 Feb 14;15:58. doi: 10.1186/s12885-015-1044-0.

42.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508. Review.

43.

Maternal factors influencing the decision to breastfeed newborns conceived with IVF.

Castelli C, Perrin J, Thirion X, Comte F, Gamerre M, Courbiere B.

Breastfeed Med. 2015 Jan-Feb;10(1):26-30. doi: 10.1089/bfm.2014.0078. Epub 2014 Nov 6.

PMID:
25375234
44.

Impact of admission medication reconciliation performed by clinical pharmacists on medication safety.

Leguelinel-Blache G, Arnaud F, Bouvet S, Dubois F, Castelli C, Roux-Marson C, Ray V, Sotto A, Kinowski JM.

Eur J Intern Med. 2014 Nov;25(9):808-14. doi: 10.1016/j.ejim.2014.09.012. Epub 2014 Sep 29.

PMID:
25277510
45.

Return to Competition in a Chronic Low Back Pain Runner: Beyond a Therapeutic Exercise Approach, a Case Report.

Veneziani S, Doria C, Falciati L, Castelli CC, Illic GF.

Eur J Transl Myol. 2014 May 21;24(3):2221. doi: 10.4081/ejtm.2014.2221. eCollection 2014 Sep 23.

46.

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg).

Donini M, Buti S, Lazzarelli S, Bozzetti R, Rivoltini L, Camisaschi C, Castelli C, Bearz A, Simonelli C, Lo Re G, Mattioli R, Caminiti C, Passalacqua R; GOIRC (Italian Oncology Group for Clinical Research).

Target Oncol. 2015 Jun;10(2):277-86. doi: 10.1007/s11523-014-0337-6. Epub 2014 Sep 19.

PMID:
25230695
47.

TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantation.

Ahmed RK, Poiret T, Ambati A, Rane L, Remberger M, Omazic B, Vudattu NK, Winiarski J, Ernberg I, Axelsson-Robertson R, Magalhaes I, Castelli C, Ringden O, Maeurer M.

J Immunother. 2014 Oct;37(8):416-25. doi: 10.1097/CJI.0000000000000047.

PMID:
25198529
48.

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy.

Tazzari M, Negri T, Rini F, Vergani B, Huber V, Villa A, Dagrada P, Colombo C, Fiore M, Gronchi A, Stacchiotti S, Casali PG, Pilotti S, Rivoltini L, Castelli C.

Br J Cancer. 2014 Sep 23;111(7):1350-62. doi: 10.1038/bjc.2014.437. Epub 2014 Aug 7.

49.

Immune response markers in sentinel nodes may predict melanoma progression.

Rodolfo M, Castelli C, Rivoltini L.

Oncoimmunology. 2014 Apr 15;3:e28498. eCollection 2014.

50.

Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies.

Castelli C, Rivoltini L, Rodolfo M, Tazzari M, Belgiovine C, Allavena P.

Cancer Immunol Immunother. 2015 Jan;64(1):83-9. doi: 10.1007/s00262-014-1576-1. Epub 2014 Jul 4. Review.

PMID:
24993564

Supplemental Content

Loading ...
Support Center